Christopher R. Manz remembers the patient who waited too long to speak about what really mattered—not survival, but time with grandchildren, moments without pain, a death that honored who she was. At Dana-Farber Cancer Institute in Boston, Manz and his team have now proven that simple, well-timed nudges can ensure more patients have that conversation before it’s too late. In a clinical trial spanning from December 2022 to September 2024, researchers tested a low-cost, high-impact intervention across two academic cancer centers: reminder emails sent to clinicians before appointments and mailed letters with questionnaires to patients facing poor prognoses. The result? A 79% increase in documented serious illness conversations within 60 days when both nudges were used—conversations that align care with personal values, ease anxiety, and empower families when patients can no longer speak for themselves.
These discussions, often deferred in the rush of treatment, are lifelines. They determine whether a patient wants aggressive intervention or peace at home, whether resuscitation aligns with their vision of dignity. Yet in oncology, they happen too infrequently and too late. The Dana-Farber trial, involving 1,051 patients and 160 clinicians, cut through the noise by targeting only those beginning treatments linked to poor outcomes—and limiting nudges to three visits. This precision mattered. "The key is precision," said co-lead author Cody E. Cotner, MD, of Harvard Medical School. "Nudging clinicians at the right time for the right patient rather than blasting reminders for every patient is how we turn this into a helpful quality improvement initiative rather than a burdensome email."
The numbers tell a quiet revolution: 79% higher odds of advance care planning documentation with combined nudges, driven largely by the clinician reminder. Even more telling, the patient preparation letter primed deeper dialogue—when people arrived thinking about what mattered most, conversations flowed more naturally. Elise Carey, MD, a palliative care specialist at Mayo Clinic Comprehensive Cancer Center not involved in the study, called it a "practical dose of hope," noting that the approach fits seamlessly into existing oncology workflows.
This isn’t about adding tasks to overstretched providers. It’s about smarter support—small signals that open space for meaning. As electronic health systems grow more complex, the lesson from Boston is refreshingly human: sometimes, all it takes is a well-placed nudge to honor a life.